Olgu Sunumu
BibTex RIS Kaynak Göster
Yıl 2022, Cilt: 39 Sayı: 2, 563 - 565, 18.03.2022

Öz

Proje Numarası

-

Kaynakça

  • Referance 1. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. Wu C., Chen X. et al. JAMA Intern. Med. 2020 doi: 10.1001 /jamainternmed.2020.0994.
  • Referance 2. Dexamethasone in Hospitalized Patients with Covid-19. The RECOVERY Collaborative Group. N Engl J Med 2021;384:693-704. DOI: 10.1056/NEJMoa2021436.
  • Referance 3. Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study. Schauwvlieghe A FAD, Rijnders BJA, Wauters J et al. Dutch-Belgian Mycosis study group. Lancet Respir Med. 2018 Oct; 6(10):782-792. doi: 10.1016/S2213-2600(18)30274-1.
  • Referance 4. Borman, A.M.; Palmer, M.D.; Fraser, M et al. COVID-19 associated invasive aspergillosis: Data from the UK National Mycology Reference Laboratory. J. Clin. Microbiol. 2020. doi: 10.1128/JCM.02136-20.
  • Referance 5. Patterson TF, Thompson GR III, Denning DW, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;63:e1–60. PubMed. doi: 10.1093/cid/ciw326.

A case report: Successful management of pulmonary aspergillosis associated with COVID ‐ 19 ARDS

Yıl 2022, Cilt: 39 Sayı: 2, 563 - 565, 18.03.2022

Öz

The recent global outbreak of coronavirus disease-19, also known as COVID-19, has infected more than 142 million people worldwide, causing more than 3 million deaths. It has been shown that up to 40% of hospitalized COVID-19 patients may develop ARDS. Although not proven, anti-inflammatory and anti-cytokine treatments are recommended to suppress the cytokine storm that develops in the early stages of the disease.
In this case report, a case of pulmonary aspergillus developed as a complication of treatment for ARDS caused by covid 19 in a 50-year-old male patient will be presented in the light of current literature.

Destekleyen Kurum

-

Proje Numarası

-

Kaynakça

  • Referance 1. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. Wu C., Chen X. et al. JAMA Intern. Med. 2020 doi: 10.1001 /jamainternmed.2020.0994.
  • Referance 2. Dexamethasone in Hospitalized Patients with Covid-19. The RECOVERY Collaborative Group. N Engl J Med 2021;384:693-704. DOI: 10.1056/NEJMoa2021436.
  • Referance 3. Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study. Schauwvlieghe A FAD, Rijnders BJA, Wauters J et al. Dutch-Belgian Mycosis study group. Lancet Respir Med. 2018 Oct; 6(10):782-792. doi: 10.1016/S2213-2600(18)30274-1.
  • Referance 4. Borman, A.M.; Palmer, M.D.; Fraser, M et al. COVID-19 associated invasive aspergillosis: Data from the UK National Mycology Reference Laboratory. J. Clin. Microbiol. 2020. doi: 10.1128/JCM.02136-20.
  • Referance 5. Patterson TF, Thompson GR III, Denning DW, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;63:e1–60. PubMed. doi: 10.1093/cid/ciw326.
Toplam 5 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Sağlık Kurumları Yönetimi
Bölüm Case Report
Yazarlar

Dursun Fırat Ergül 0000-0001-6670-4877

Maruf Boran Bu kişi benim 0000-0002-2494-9152

Proje Numarası -
Erken Görünüm Tarihi 18 Mart 2022
Yayımlanma Tarihi 18 Mart 2022
Gönderilme Tarihi 29 Eylül 2021
Kabul Tarihi 5 Ocak 2022
Yayımlandığı Sayı Yıl 2022 Cilt: 39 Sayı: 2

Kaynak Göster

APA Ergül, D. F., & Boran, M. (2022). A case report: Successful management of pulmonary aspergillosis associated with COVID ‐ 19 ARDS. Journal of Experimental and Clinical Medicine, 39(2), 563-565.
AMA Ergül DF, Boran M. A case report: Successful management of pulmonary aspergillosis associated with COVID ‐ 19 ARDS. J. Exp. Clin. Med. Mart 2022;39(2):563-565.
Chicago Ergül, Dursun Fırat, ve Maruf Boran. “A Case Report: Successful Management of Pulmonary Aspergillosis Associated With COVID ‐ 19 ARDS”. Journal of Experimental and Clinical Medicine 39, sy. 2 (Mart 2022): 563-65.
EndNote Ergül DF, Boran M (01 Mart 2022) A case report: Successful management of pulmonary aspergillosis associated with COVID ‐ 19 ARDS. Journal of Experimental and Clinical Medicine 39 2 563–565.
IEEE D. F. Ergül ve M. Boran, “A case report: Successful management of pulmonary aspergillosis associated with COVID ‐ 19 ARDS”, J. Exp. Clin. Med., c. 39, sy. 2, ss. 563–565, 2022.
ISNAD Ergül, Dursun Fırat - Boran, Maruf. “A Case Report: Successful Management of Pulmonary Aspergillosis Associated With COVID ‐ 19 ARDS”. Journal of Experimental and Clinical Medicine 39/2 (Mart 2022), 563-565.
JAMA Ergül DF, Boran M. A case report: Successful management of pulmonary aspergillosis associated with COVID ‐ 19 ARDS. J. Exp. Clin. Med. 2022;39:563–565.
MLA Ergül, Dursun Fırat ve Maruf Boran. “A Case Report: Successful Management of Pulmonary Aspergillosis Associated With COVID ‐ 19 ARDS”. Journal of Experimental and Clinical Medicine, c. 39, sy. 2, 2022, ss. 563-5.
Vancouver Ergül DF, Boran M. A case report: Successful management of pulmonary aspergillosis associated with COVID ‐ 19 ARDS. J. Exp. Clin. Med. 2022;39(2):563-5.